Status: Not yet recruiting
EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer
This is an open label phase II study to determine the safety and preliminary efficacy of photoimmunotherapy (PIT) for patients with locally advanced and borderline resectable pancreatic cancer.
Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Brown UniversityUpdated: Jul 13, 2026Locations: 1
Eligibility criteria
Pathologically confirmed pancreatic adenocarcinoma. [+10]
Patients with distant metastases. [+9]